Exercise and Relaxation Intervention for Young Adult Cancer Survivors
Status: | Completed |
---|---|
Conditions: | Cancer, Cancer |
Therapuetic Areas: | Oncology |
Healthy: | No |
Age Range: | 18 - 39 |
Updated: | 4/2/2016 |
Start Date: | July 2009 |
End Date: | December 2013 |
Contact: | Carolyn Rabin, PhD |
Email: | CRabin@lifespan.org |
Phone: | (401)793-8234 |
The purpose of this study is to develop an exercise and relaxation program for young adults
(age 18 to 39) who have completed their treatment for cancer.
(age 18 to 39) who have completed their treatment for cancer.
There is evidence that cancer diagnosis and treatment during young adulthood puts survivors
at risk for a number of medical and psychosocial difficulties including cardiovascular
disease, second cancers and psychological distress. The proposed research is aimed at
developing a physical activity and relaxation intervention for young adult cancer survivors
in order to address some of their medical and psychosocial risks. The objective of the study
is to pilot test a 12-week physical activity and relaxation intervention in this population.
We hypothesize that the intervention will be feasible for and acceptable to young adult
cancer survivors. We also hypothesize that the intervention group will demonstrate increased
levels of physical activity, improved mood and reduced fatigue relative to the wait list
control group at the 12-week and 24-week follow-up assessments; statistically significant
differences may not be found due to the small sample size, however. In addition, we will
conduct exploratory tests of intervention effects on fitness, flexibility, body mass, and
waist circumference. Sixty participants will be recruited for the pilot study. Participants
will be randomly assigned to receive a 12-week physical activity and relaxation intervention
or to a wait list control group. Intervention group participants will receive 12 weeks of
behavior change counseling, based on the Transtheoretical Model and Social Cognitive Theory,
to help them adopt a program of brisk walking and learn mindfulness meditation. They will
also be given access to an online discussion group. Participants in both arms of the study
will be assessed at baseline, 12 weeks, and 24 weeks. Following the 24-week assessment, wait
list control participants will offered the 12-week intervention and one additional
assessment (i.e., at 36 weeks). Data will be collected on intervention feasibility (e.g.,
number of counseling sessions delivered) and acceptability (e.g., general satisfaction
ratings). ANCOVAs will be used to conduct preliminary tests of intervention effects (e.g.,
on physical activity, mood, and fatigue).
at risk for a number of medical and psychosocial difficulties including cardiovascular
disease, second cancers and psychological distress. The proposed research is aimed at
developing a physical activity and relaxation intervention for young adult cancer survivors
in order to address some of their medical and psychosocial risks. The objective of the study
is to pilot test a 12-week physical activity and relaxation intervention in this population.
We hypothesize that the intervention will be feasible for and acceptable to young adult
cancer survivors. We also hypothesize that the intervention group will demonstrate increased
levels of physical activity, improved mood and reduced fatigue relative to the wait list
control group at the 12-week and 24-week follow-up assessments; statistically significant
differences may not be found due to the small sample size, however. In addition, we will
conduct exploratory tests of intervention effects on fitness, flexibility, body mass, and
waist circumference. Sixty participants will be recruited for the pilot study. Participants
will be randomly assigned to receive a 12-week physical activity and relaxation intervention
or to a wait list control group. Intervention group participants will receive 12 weeks of
behavior change counseling, based on the Transtheoretical Model and Social Cognitive Theory,
to help them adopt a program of brisk walking and learn mindfulness meditation. They will
also be given access to an online discussion group. Participants in both arms of the study
will be assessed at baseline, 12 weeks, and 24 weeks. Following the 24-week assessment, wait
list control participants will offered the 12-week intervention and one additional
assessment (i.e., at 36 weeks). Data will be collected on intervention feasibility (e.g.,
number of counseling sessions delivered) and acceptability (e.g., general satisfaction
ratings). ANCOVAs will be used to conduct preliminary tests of intervention effects (e.g.,
on physical activity, mood, and fatigue).
Inclusion Criteria:
- age 18 to 39
- diagnosed with any form of cancer (except non-melanoma skin cancer)
- diagnosed between age 18 and 39 in the past 10 years
- completed all surgery, chemotherapy and radiation therapy
- currently in a cancer remission
- able to speak and write English fluently
- sedentary (i.e., not regularly physically active)
- not currently engaging in a relaxation strategy
- score above a cutoff on a fatigue screener
Exclusion Criteria:
- the intention to get pregnant
- the presence of a known medical condition or history of severe psychiatric illness
that would make participation dangerous or very difficult
We found this trial at
1
site
Miriam Hospital The Miriam Hospital is a private, not-for-profit hospital, with a history of providing...
Click here to add this to my saved trials
![](https://www.clinicaltrialsgps.com/wp-content/themes/GPS/media//img/tooltip-arrow.png)